Biogen Pharmachem Intrinsic Value
BIOGEN Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹1.88 | ₹1.69 - ₹2.07 | +150.7% | Book Value/Share: ₹14.15, P/B: 0.8x |
| Revenue Multiple Method | revenue | ₹0.46 | ₹0.41 - ₹0.51 | -38.7% | Revenue/Share: ₹0.46, P/S: 1.0x |
| EBITDA Multiple Method | earnings | ₹0.30 | ₹0.27 - ₹0.33 | -60.0% | EBITDA: ₹2.00Cr, EV/EBITDA: 5x |
| Simple DCF (5Y) | dcf | ₹1.88 | ₹1.50 - ₹2.26 | +150.7% | CF Growth: 5.0%, Discount: 15% |
Want to compare with current market value? Check BIOGEN share price latest .
Valuation Comparison Chart
BIOGEN Intrinsic Value Analysis
What is the intrinsic value of BIOGEN?
Based on our comprehensive analysis using 4 different valuation methods, the estimated intrinsic value of Biogen Pharmachem (BIOGEN) is ₹1.88 (median value). With the current market price of ₹0.75, this represents a +150.7% variance from our estimated fair value.
The valuation range spans from ₹0.30 to ₹1.88, indicating ₹0.30 - ₹1.88.
Is BIOGEN undervalued or overvalued?
Based on our multi-method analysis, Biogen Pharmachem (BIOGEN) appears to be trading below calculated value by approximately 150.7%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Debt to Equity Ratio | 1.00 | Industry Standard: <0.5 | Below 1.0 | Indicates financial leverage level |
| Return on Equity | 2.2% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Asset Turnover Ratio | 0.03x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
Related Pages for Biogen Pharmachem
Additional stock information and data for BIOGEN
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-1 Cr | ₹-18 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹2 Cr | ₹1 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹2 Cr | ₹1 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 7/10 |
| March 2021 | ₹4 Cr | ₹2 Cr | Positive Free Cash Flow | 7/10 |